NRx Pharmaceuticals completed ketamine manufacturing validation and 2-year stability testing, enabling commercial readiness but not FDA approval.

A few weeks ago, a certain wind began to blow through our legal streets, and it appears to be gaining momentum. It carries a ...

Microsoft confirmed Monday that it has pulled out of a UK AI data centre deal with British start-up Nscale, in a blow to the ...

PBB chief Avante warns that an oil shock and weak peso are a "big blow" to the Philippine economy, driving up inflation and ...

Prince Harry has been slammed for his peace-destroying move amid reconciliaton and reunion speculation with senior royals.The ...

You would imagine that by the time the youngest of my three daughters hit year nine, I would have been able to save her from ...

Used to measure a player's impact on the game, represented by the difference between their team's total scoring versus their ...

Spread the loveYou’ve heard the buzz, right? Artificial intelligence is everywhere, from your smartphone to self-driving cars ...

Kingfisher Mining Ltd (ASX:KFM) last week outlined plans to accelerate exploration at its Copper Blow Project near Broken ...

Andoni Iraola has offered the latest update on Dominik Szoboszlai and Jeremie Frimpong after they limped off while playing ...

Daniel Jones completed 22-of-42 passes for 269 yards, one touchdown and two interceptions in the Colts' 26-20, Week 6 loss to ...

Thanks to the fund's substantial discount, the fund's distribution rate gets a relative boost up to 8.7% compared to the NAV ...